Listen

Description

From WHO: WHO Director-General Dr Tedros Adhanom Ghebreyesus congratulated all involved in bringing an end to the 12th Ebola outbreak in the eastern Democratic Republic of the Congo
From Health Canada During a virtual news conference, members of the National Advisory Committee on Immunization (NACI) join Dr. Howard Njoo, Canada’s deputy chief public health officer, for an update on guidance regarding the Janssen COVID-19 vaccine from Johnson & Johnson. Taking part in the briefing are Drs. Caroline Quach-Thanh, chair of NACI, Shelley Deeks, vice-chair of NACI, and Matthew Tunis, executive secretary of NACI. NACI recommends that the Janssen vaccine may be offered to people ages 30 and over if the individual prefers an earlier vaccine rather than waiting for an mRNA vaccine, and if the benefits outweigh the risks. On April 30, Health Canada announced it was holding off on distributing 300,000 doses of this vaccine due to a possible quality control issue.
Public Health British Columbia Over the coming month, more than one million vaccine doses will be delivered to our province, with more anticipated for June, giving the vast majority of eligible people access to a vaccine before Canada Day.

“We are moving as quickly as possible to get vaccine into arms, which means at times, there will be bumps along the way in our rollout and delivery. Importantly, when those bumps occur, we will pivot and adjust to keep moving forward.

Become a supporter of this podcast: https://www.spreaker.com/podcast/policy-and-rights--3339563/support.